Further Information
CACNB2, calcium channel, voltage-dependent, beta 2 subunit, CACNLB2, CAVB2, FLJ23743, MYSB, CAB2, calcium channel voltage-dependent subunit beta 2, lambert-Eaton myasthenic syndrome antigen B, myasthenic (Lambert-Eaton) syndrome antigen B, voltage-dependent L-type calcium channel subunit beta-2
Peptide ELISA: antibody detection limit dilution 1:4000.Western Blot:Approx 65kDa band observed in lysates of cell lines NIH3T3 and Jurkat (calculated MW of 68.1kDa according to NP_000715.2). Recommended concentration: 1-3ug/ml.
Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
Aliquot and store at -20?C. Minimize freezing and thawing.
500 ug/mL
Unconjugated
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
Expected Species Reactivity based on sequence homology: Rat, Dog, Cow
The immunogen for this antibody is: ECNKQRSRHKSKDRY
783
calcium channel, voltage-dependent, beta 2 subunit
CACNB2
Homo sapiens
Liquid
PREDICTED MOLECULAR WEIGHT:
Approx 65 kDa
NP_000715.2, NP_963890.2, NP_963884.2, NP_963891.1, NP_963887.2, NP_963865.2, NP_963864.1, NP_963866.2, NP_001161417.1
148232726
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
This antibody is expected to recognize all reported isoforms (NP_000715.2; NP_963890.2; NP_963884.2; NP_963891.1; NP_963887.2; NP_963865.2; NP_963864.1; NP_963866.2; NP_001161417.1).
Q08289